Journal of Clinical Medicine Research
Ectopic Adipose Tissue Depots and Metabolic-Associated Fatty Liver Disease: Relationships With Vitamin D
Cross-sectional study of 303 peoplePopulations
Metabolic-associated fatty liver disease
Papers on metabolic-associated fatty liver disease
38 papers1 new in 30 days
Saturday, October 31
Wednesday, September 16
Journal of Public Health and Preventive Medicine
Development and Internal Validation of an Interpretable Machine Learning Screening Model for MAFLD–Diabetes Mellitus Comorbidity: A Cross-Sectional NHANES Study
Cross-sectional study of 5,383 peopleDiabetes mellitus
Wednesday, September 2
Indian Journal of Pharmacology
Pharmacological management of obesity: Current landscape and emerging therapies
![Classification of obesity.[38] BMI: Body mass index](/_next/image?url=%2Ffig%2FMED-42683980%2Ff5fa9110.webp&w=1600&q=75&dpl=447e1e9e6a04)
ReviewObesity
Thursday, August 13
International Journal of Molecular Sciences
Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion
Experiments in miceSIRT6
Wednesday, June 24
Diabetology & Metabolic Syndrome
Association of frailty and metabolism with multi-state model in fatty liver disease, diabetes mellitus and all-cause mortality
Cohort study of 165,555 peopleMetabolic syndrome
Friday, May 29
Zhonghua Gan Zang Bing Za Zhi
Research progress on cellular senescence and liver diseases
ReviewCellular senescence
Thursday, May 7
Frontiers in Nutrition
Analysis of the correlation and predictive performance of GNRI, CONUT, and PNI with MAFLD in Chinese adult physical examination population
Cross-sectional study of 10,901 peopleBiomarkers
Tuesday, March 31
Thursday, March 19
Friday, February 27
Nutrition, Metabolism, and Cardiovascular Diseases
Dynamic FIB-4 trajectory and a multi-state Markov model analysis reveal fibrosis progression and cardiovascular-cerebrovascular risk in MAFLD patients
Cohort study of 5,777 peopleFIB-4
Tuesday, February 24
Tuesday, January 20
Nutrition & Metabolism
Efficacy and safety of lower-carbohydrate dietary patterns for metabolic associated fatty liver disease: evidence from randomized controlled trials with grade analysis
Meta-analysis of randomized trialsInterventions
Saturday, January 17
Pakistan Journal of Pharmaceutical Sciences
Clinical efficacy and mechanism of polyene phosphatidylcholine combined with atorvastatin in treating metabolic associated fatty liver disease
Non-randomized trial in 92 peopleAtorvastatin
Friday, January 16
Molecular Nutrition & Food Research
Oxidative Balance Score, Genetic Predictors of the Gut Microbiome, and the Risk of Metabolic-Associated Fatty Liver Disease: A Cohort Study
Cohort study of 182,601 peoplePopulations
Wednesday, January 14
Frontiers in Physiology
Exercise and the hepatic sirtuin network: rethinking the research focus on SIRT1, SIRT3, and SIRT6
CommentaryExercise
Monday, November 17
Contemporary Clinical Trials
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial
Randomized trial in 349 peopleMazdutide
Wednesday, November 5
Frontiers in Medicine
Predicting the risk of metabolic-associated fatty liver disease in the elderly population in China: construction and evaluation of interpretable machine learning models
Cross-sectional study of 2,635 peopleBiomarkers
Thursday, October 23
ENDO 2025 Abstract
MON-733 Clinical Adiposity Based Chronic Disease Management, experiences from the clinic post COVID
Cohort study in peopleInterventions
Wednesday, October 1
International Journal of Endocrinology
Unveiling Tirzepatide's Therapeutic Spectrum: A Dual GIP/GLP-1 Agonist Targeting Metabolic, Neurological, and Cardiovascular Health
ReviewGLP-1 receptor agonists
Thursday, February 20
Nutrition & Metabolism
Effect of time-restricted feeding and caloric restriction in metabolic associated fatty liver disease in male rats
Experiments in ratsDietary restriction
Tuesday, November 26
Thursday, October 3
Journal of Translational Internal Medicine
Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)
ReviewIndustry & policy
Saturday, September 28
Biomedicines
Metabolic-Associated Fatty Liver Disease and Cognitive Performance in Type 2 Diabetes: Basal Data from the Phytate, Neurodegeneration and Diabetes (PHYND) Study
Cross-sectional study of 219 peopleType 2 diabetes
Wednesday, September 4
Frontiers in Nutrition
Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial
Randomized trial in 60 peopleDietary restriction
Thursday, August 1
Metabolic Syndrome and Related Disorders
Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials-A Short Review
ReviewInterventions
Friday, March 22
World Journal of Gastroenterology
Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
CommentaryMuscle
Monday, January 15
Clinics and Research in Hepatology and Gastroenterology
Association of composite dietary antioxidant index and muscle mass in individuals with metabolic associated fatty liver disease
Cross-sectional study of 956 peopleMuscle
Thursday, November 16
Nutrition & Diabetes
Metabolic associated fatty liver disease and sarcopenia additively increase mortality: a real-world study
Cohort study of 13,692 peopleSarcopenia
Friday, September 22
Liver International
Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Cross-sectional study of 184,792 peoplePopulations
Friday, July 21
Research Square
Lower creatinine to cystatin C ratio is associated with an increased risk of MAFLD: A cross-sectional and prospective study of 368,634 UK Biobank participants
Preprint: cohort study of 368,634 peopleCystatin C